This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
11 May 2016  |  Asia Pacific  |  Market Outlook
Asia-Pacific Telehealth Market Outlook, Forecast to 2020
Shifting Cost and Consumer Trends to Support Innovative Delivery Models Driven by mHealth, Remote Patient Monitoring and Telemedicine
Healthcare industry challenges including aging populations, rising incidence of chronic diseases, and the need to manage care costs better are necessitating the adoption of innovative care delivery models. While healthcare providers and consumers are displaying a perceivable behavior shift in the way they interact with health technologies, vendors ...
$4,950.00 -
18 Apr 2016  |  Asia Pacific  |  Market Outlook
Asia-Pacific Healthcare Outlook, 2016
Clinical Wearables, Regenerative Medicines and Biosimilars Set for Strong Growth
Demand for healthcare services will continue to grow in Asia-Pacific (APAC) under the influence of demographic and epidemiological transitions impacting the entire region. APAC governments which shoulder the largest burden of paying for healthcare services will take decisive steps to innovate their healthcare systems in order to face future challen...
$4,950.00 -
30 Sep 2015  |  Europe  |  Technology Research
Advanced mechanisms in drug delivery
Impact and assessment of modern mechanisms in drug delivery systems
The research service aims to give a global outlook of the companion diagnostic market landscape, with a specific focus on Western European countries. The segments related to oncology discussed in this study include breast cancer, lung cancer, colorectal cancer and other cancers, and non-oncology related infectious disease, CNS, and cardiovascular. ...
$4,950.00 -
10 Jun 2015  |  Asia Pacific  |  Market Outlook
Vietnam Healthcare Outlook
Value Propositions and Market Entry Guides for Investors
This research service provides an analysis for the healthcare market in Vietnam. In addition to an overview of the total healthcare market, it presents detailed analyses of current trends, market sizes, revenue forecasts, and drivers and restraints for the hospital (private and public) market, and for the manufacturing and distribution of medical d...
$4,950.00 -
18 May 2015  |  Asia Pacific  |  Market Outlook
2015 Asia-Pacific Healthcare Industry Outlook
APAC will Continue to Remain in Global Spotlight for Investment, Innovation, and Growth in Healthcare
The research service provides an analysis of the healthcare market in Asia-Pacific (APAC). It discusses the current technology and country-specific trends and provides predictions. Market participants and key opinion leaders in APAC hospitals were interviewed to obtain their views on trends and opportunities in the healthcare industry. The regional...
$2,450.00 -
03 Jul 2014  |  Asia Pacific  |  Market Outlook
2014 Asia-Pacific Medical Devices Outlook
Changing Demographics and Landscape Set Stage for the Future
Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...
$3,950.00 -
21 Mar 2014  |  Asia Pacific  |  Market Outlook
Asia-Pacific Healthcare Outlook - 2014
Changing Landscape Impacting Lives
The study presents an outlook of the healthcare market in the Asia-Pacific. Good healthcare service can impact social issues, economics, and even the politics of a country. Governments need to meet these expectations, but rising costs in population and demographic shifts are causing them to falter. Disparity in care levels is also a concern, especi...
$4,950.00 -
30 Dec 2013  |  Europe  |  Technology Research
The Untapped Potential in Live Cell Imaging (Technical Insights)
Improved cellular dynamics in disease diagnostic and drug discovery.
The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented...
$4,950.00 -
30 Jul 2013  |  Europe  |  Technology Research
Top Technologies in Health and Wellness--2013 (Technical Insights)
Rewriting Life…
This research service offers an assessment for marketed and pipeline products for the global ACS therapeutics market. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are br...
$4,950.00